Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-12, Stock:PFE, The news for the past five days is as follows:
2019-03-05: NEWS1: Lilly to Bring Half-Priced Version of Popular Humalog Insulin.NEWS2: Pfizer and Mylan: How Capex, Interest Expenses, and Debt Stack Up.NEWS3: AnTolRx Announces Pfizer Exercises Option To License Immune Tolerance Therapy For Potential Treatment Of Type 1 Diabetes.NEWS4: Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference.NEWS5: Health Care Sector Update for 03/05/2019: ADMS, NNVC, NVTA, JNJ, PFE, MRK, ABT, AMGN.NEWS6: Health Care Sector Update for 03/05/2019: ADMS, NNVC, NVTA, JNJ, PFE, MRK, ABT, AMGN.NEWS7: Comparing Dividends and Free Cash Flow for Pfizer and Mylan.NEWS8: Lilly to Bring Half-Priced Version of Popular Humalog Insulin.NEWS9: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS10: Pfizer or Mylan: Who Is Controlling Expenses Better?.NEWS11: The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings.NEWS12: [$$] Scott Gottlieb to step down as head of FDA.NEWS13: Pfizer Prices $5,000,000,000 Debt Offering.
2019-03-06: NEWS1: Lilly's Emgality Gets FDA Priority Review for Cluster Headache.NEWS2: Lilly's Emgality Gets FDA Priority Review for Cluster Headache.NEWS3: The Roche Merger Will Do Wonders for Spark Stock.NEWS4: GlycoMimetics Inc (GLYC) Q4 2018 Earnings Conference Call Transcript.NEWS5: Lilly's Emgality Gets FDA Priority Review for Cluster Headache.NEWS6: ‘Demographics are favorable’ for the healthcare sector.NEWS7: Health Care Sector Update for 03/06/2019: VLRX, OPTN, INFI, JNJ, PFE, MRK, ABT, AMGN.NEWS8: Health Care Sector Update for 03/06/2019: VLRX, OPTN, INFI, JNJ, PFE, MRK, ABT, AMGN.
2019-03-07: NEWS1: Notable Two Hundred Day Moving Average Cross - PFE.NEWS2: Notable Two Hundred Day Moving Average Cross - PFE.NEWS3: Syndax Pharmaceuticals Sheds 12.5% After Q4 Miss, Studies Fail to Meet Primary Endpoints.NEWS4: Syndax Pharmaceuticals Sheds 12.5% After Q4 Miss, Studies Fail to Meet Primary Endpoints.NEWS5: After Hours Most Active for Mar 7, 2019 :  LTHM, MSFT, S, GE, F, MRO, PFE, GLPI, PTEN, MNST, EBAY, RMBS.NEWS6: After Hours Most Active for Mar 7, 2019 :  LTHM, MSFT, S, GE, F, MRO, PFE, GLPI, PTEN, MNST, EBAY, RMBS.NEWS7: 5 Top Gene-Editing Stocks for 2019.NEWS8: Health Care Sector Update for 03/07/2019: GTXI, BPTH, CODX, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 03/07/2019: GTXI, BPTH, CODX, JNJ, PFE, ABT, MRK, AMGN.
2019-03-08: NEWS1: After Hours Most Active for Mar 8, 2019 :  LLY, PFE, ORCL, MRO, JD, QQQ, EBAY, T, GE, URBN, MSFT, IEF.NEWS2: After Hours Most Active for Mar 8, 2019 :  LLY, PFE, ORCL, MRO, JD, QQQ, EBAY, T, GE, URBN, MSFT, IEF.NEWS3: Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs.NEWS4: Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs.NEWS5: Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs.NEWS6: Exchange Traded Funds: How To Find The Best ETFs.NEWS7: Health Care Sector Update for 03/08/2019: SEEL, ACET, ARDX, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 03/08/2019: SEEL, ACET, ARDX, JNJ, PFE, ABT, MRK, AMGN.
2019-03-11: NEWS1: U.S. FDA Approves Pfizer’s Oncology Biosimilar TRAZIMERA™ (trastuzumab-qyyp), a Biosimilar to Herceptin®1.NEWS2: Stocks Spike on M&A and Retail Sales.NEWS3: FDA approves Pfizer's biosimilar to Roche's Herceptin.NEWS4: FDA approves Pfizer's biosimilar to Roche's Herceptin.NEWS5: Conatus' (CNAT) Q4 Earnings Top Estimates, Emricasan in Focus.NEWS6: Conatus' (CNAT) Q4 Earnings Top Estimates, Emricasan in Focus.NEWS7: The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's.NEWS8: The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's.NEWS9: Conatus' (CNAT) Q4 Earnings Top Estimates, Emricasan in Focus.NEWS10: The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's.NEWS11: Health Care Sector Update for 03/11/2019: AXGT, LCI, HRC, JNJ, PFE, MRK, ABT, AMGN.NEWS12: Health Care Sector Update for 03/11/2019: AXGT, LCI, HRC, JNJ, PFE, MRK, ABT, AMGN.

Answer: Rise